Foundation Medicine
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Foundation Medicine generated cash of -$120,991,000, which is less than the previous year. Cash used in financing activities reached the amount of $65,949,000 last year. Net change in cash is therefore $7,787,000.

Cash Flow

Foundation Medicine, Inc. (NASDAQ:FMI): Cash Flow
2013 -30.76M -8.49M 108.71M
2014 -42.73M -8.82M -650K
2015 -63.72M -140.71M 250.12M
2016 -67.16M 12.68M 333K
2017 -120.99M 62.82M 65.94M

FMI Cash Flow Statement (2013 – 2017)

2017 2016 2015 2014 2013
Cash at beginning of period
63.61M117.76M72.08M124.29M54.83M
Operating activities
Net income
-161.46M-113.19M-89.63M-52.22M-42.94M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
18.51M15.94M10.6M8.19M5.00M
Stock-based compensation expense
22.20M19.52M11.17M5.98M7.31M
Deferred income tax benefit 22.20M19.52M11.17M5.98M7.31M
Changes in operating assets and liabilities:
Accounts receivable, net
-11.72M-844K2.36M-3.63M-4.06M
Inventories
-2.57M-2.44M-3.28M-3.04M-960K
Accounts payable
8.43M5.06M-1.55M3.11M1.67M
Cash generated by operating activities
-120.99M-67.16M-63.72M-42.73M-30.76M
Investing activities
Purchases Of Investments
-4.99M-107.45M-114.75M00
Investments In Property Plant And Equipment
-15.65M-20.87M-25.43M-9.68M-6.93M
Acquisitions Net
00000
Cash generated by investing activities
62.82M12.68M-140.71M-8.82M-8.49M
Financing activities
Common Stock Issued
00245.38M0110.38M
Payments for dividends
00000
Repurchases of common stock
0000-10K
Repayments of term debt
60M00-1.28M-1.70M
Cash used in financing activities
65.94M333K250.12M-650K108.71M
Net Change In Cash
7.78M-54.14M45.68M-52.21M69.45M
Cash at end of period
71.40M63.61M117.76M72.08M124.29M